Pastora Maria de Araújo Duarte
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Pastora Maria de Araújo Duarte has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Fernando Barroso Duarte
Hospital Universitário Walter Cantídio – Fortaleza (CE), Brazil
2 shared publications - Romélia Pinheiro Gonçalves Lemes
Universidade Federal do Ceará, Fortaleza, Brazil
2 shared publications - Beatrice Araújo Duarte
Universidade Federal de São Paulo São Paulo Brazil
1 shared publication - Deivide de Sousa Oliveira
Clinical Genetics Laboratory, Drug Research and Development Center (NPDM), Department of Medicine, Federal University of Ceará, Fortaleza 60430-275, CE, Brazil
1 shared publication - Francisco Andre Gomes Bastos Filho
Centro Universitário Christus (UNICHRISTUS)
1 shared publication - Francisco Dario Rocha Filho
Hospital Universitário Walter Cantídio, Brasil
1 shared publication
Latest Publications
- Open Access
- 1 October 2020
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 66 (10) , 1335-1337
Renal changes in COVID-19 infection
SUMMARY The COVID-19 (SARS-CoV-2) infection started in China, Wuhan City, Hubei Province, in December 2019, and it was declared a pandemic in mid-March 2020, caused by a new coronavirus strain called SARS-CoV-2. The pathogenesis of kidney injury attributed to SARS- CoV-2 is not well defined yet. Observations show that the kidney damage caused by the new virus mutation is mainly tubular, with impairment of glomerular filtration and high levels of urea and creatinine. A study with seriously ill patients with COVID-19 showed that acute kidney injury was present in 29%. In the face of this evidence, based on recent studies, we can see the great renal contribution as an impact factor in the evolution of COVID-19, not just as a complicator of severity, but maybe part of the initial cascade of the process, requiring a deeper analysis using conventional biomarkers of kidney injury and more aggressive clinical intervention in patients at risk, in an attempt to reduce mortality.
- 1 October 2020
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 66 (10) , 1335-1337
Open AccessRenal changes in COVID-19 infection
SUMMARY The COVID-19 (SARS-CoV-2) infection started in China, Wuhan City, Hubei Province, in December 2019, and it was declared a pandemic in mid-March 2020, caused by a new coronavirus strain called SARS-CoV-2. The pathogenesis of kidney injury attributed to SARS- CoV-2 is not well defined yet. Observations show that the kidney damage caused by the new virus mutation is mainly tubular, with impairment of glomerular filtration and high levels of urea and creatinine. A study with seriously ill patients with COVID-19 showed that acute kidney injury was present in 29%. In the face of this evidence, based on recent studies, we can see the great renal contribution as an impact factor in the evolution of COVID-19, not just as a complicator of severity, but maybe part of the initial cascade of the process, requiring a deeper analysis using conventional biomarkers of kidney injury and more aggressive clinical intervention in patients at risk, in an attempt to reduce mortality.
- Open Access
- 1 July 2019
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 65 (7) , 934-936
Interstitial nephritis associated with nivolumab in a patient with hodgkin lymphoma
- 1 July 2019
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 65 (7) , 934-936
Open AccessInterstitial nephritis associated with nivolumab in a patient with hodgkin lymphoma